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Abstract— Scaffolds are artificial structures that replace 
the natural extracellular matrix (ECM). Scaffolds are 
capable of supporting three dimensional tissue 
formations. The natural ECM performs functions, like 
regulating intercellular communication along with 
providing support to the cells. A variety of fabricating 
methods are adopted for preparing scaffolds from a wide 
range of available biomaterials. The scaffolds thus 
produced can function as a successful scaffold only if they 
satisfy the necessary parameters. The suitability of any 
scaffold for tissue engineering application is tested by 
using a battery of tests that is a combination of 
mechanical and biological tests. This paper reviews the 
test methods adopted by researchers to test the suitability 
of scaffolds for tissue engineering applications. 
Keywords— Biodegradability, Cytotoxicity, Porosity, 
Proliferation,  Scaffolds. 
 
I. INTRODUCTION 
A biomaterial is any substance (other than drugs) or 
combination of substances synthetic or natural in origin, 
which can be used for any period of time, as a whole or a 
part of a system which treats, augments, or replaces any 
tissue, organ or function of the body. Biomaterials may be 
natural or synthetic. Polymers, biopolymers, metals, 
ceramics and composites have been researched for their 
suitability as a biomaterial. Attempts are made to replace 
petrochemical products by renewable, bio sourced 
materials like starch, collagen, gelatin, alginate, cellulose 
and chitin [1,2]. The biomaterials are used to design 
scaffolds by the scaffold fabrication techniques like 
textile technologies, particulate leaching techniques, 
phase separation and rapid prototyping techniques [3]. 
Each fabricating technique produces a scaffold of a 
different characteristic nature. There are a few basic 
requirements that a scaffold must satisfy. The scaffold 
provides a framework and initial support for the cells to 
attach, proliferate, differentiate and form an extracellular 
matrix (ECM) [4]. The design aspect along with the 
choice of the material for the artificial scaffold is  
very crucial to cell differentiation, adhesion, proliferation, 
and the transport of the growth factors or other bio 
molecular signals [5]. 
An ideal scaffold should have the following 
characteristics: (i) an extensive network of  
interconnecting pores so that cells can migrate, multiply 
and attach deep within the scaffolds; (ii) channels through 
which oxygen and nutrients are provided to cells deep 
inside the scaffold, and the waste products can be easily 
carried away; (iii) biocompatibility with a high affinity 
for cells to attach and proliferate; (iv) right shape, 
however complex as desired by the surgeon; and (v) 
appropriate mechanical strength and biodegradation 
profile. Tissue engineering would greatly benefit from 
such scaffolds [6]. 
The aim of this paper is to review the test methods like 
cytotoxicity, MTT assay, DAPI assay, FTIR adopted to 
judge the suitability of a scaffold for tissue engineering 
applications. 
 
II. CYTOTOXICITY 
The cytotoxicity of the biomaterial selected for tissue 
engineering application is the first step towards producing 
a suitable scaffold for tissue engineering.  
2.1 Test for cytotoxicity 
International Standard ISO 10993-5:2009(E), Biological 
Evaluation of Medical Devices, Part 5: Tests for In vitro 
cytotoxicity are designed to determine the biological 
response of mammalian cells in vitro using appropriate 
biological parameters. An extract of the scaffold sample 
is tested for cytotoxicity.  It measures cell viability via 
metabolic activity. Yellow water-soluble MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5- diphenyl tetrazolium bromide) 
is metabolically reduced in viable cells to a blue-violet 
insoluble formazan. The number of viable cells correlates  
to the colour intensity determined by photometric 
measurements after dissolving the formazan in alcohol. 
Cells are seeded into 96-well plates and maintained in 
culture for 24 h. They are then exposed to the test 
compound over a range of concentrations. After 24 h 
exposure, the formazan formation is determined for each 
treatment concentration and compared to that determined 
in control cultures. For each treatment the percentage 
inhibition of growth is calculated. 
A decrease in number of living cells results in a decrease 
in the metabolic activity in the sample. This decrease 
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directly correlates to the amount of blue-
formed, as monitored by the optical density at 570 nm. 
calculate the reduction of viability compared to the blank
the following equation (1) is used. 
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where  
OD570e is the mean value of the measured optical 
density of the 100 % extracts of the test sample;
OD570b is the mean value of the measured optical 
density of the blanks. 
The lower the Viab.% value, the higher the cytotoxic 
potential of the test item is. If viability is reduced to < 70 
% of the blank, it has a cytotoxic potential. The 50 % 
extract of the test sample should have at least the same or 
a higher viability than the 100 % extract; otherwise the 
test should be repeated. 
 
III. PORE SIZE 
3.1 Importance of Pore Size 
The next important property to be tested for a scaffold is 
its pore size. The porosity of the scaffold allows the 
transport of oxygen and nutrients to be provided to cells 
deep inside the scaffold, and the waste products can 
easily carried away. Simply producing a highly porous 
scaffold and seeding it with the appropriate types of cells 
in most cases does not reproduce the desired feature of a 
normal tissue [6]. 
The subcellular structures (1–10 mm) to control the 
cellular environment, cell scale structures (10
to control cell–cell inter-relationships, and supracellular 
scale structures (100–1000 mm) to build the essential 
functional units of the tissue are the pore sizes that are 
essential for various functions as described by Bhatia and 
Chen, 1999 [7]. 
3.2 Measurement of Pore Size: 
Pore size is measured in different ways. K Katoh et al 
measured the porosity by using the formula  Porosity(%) 
=(ρ keratin– ρ sponge)/ ρ keratin x 100, where 
was the density of a dense S-sulfo keratin plate prepared 
by compression-molding the S-sulfo keratin
mixture, dissolving out urea and lyophilizing. The density 
of keratin plate was measured using a 50 ml pycnometer 
with ethanol, where the density of ethanol w
g/cm3 at 20oC [8]. 
Nayak and Gupta determined the apparent porosity of the 
scaffold by applying the Archimedes principle and its 
calculation was done by using dry, soaked and suspended 
weights of the scaffolds using the equation
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(2)                                    
W1 = dry weight of the scaffold, 
W2 = soaked weight of the scaffold, and W3 = suspended 
weight of the scaffold [9]. 
Pore size is also observed under a scanning electron 
microscope (SEM). 
Fig. 1: Images of kerateine disks prior to subcutaneous 
implantation. A digital photo shows a macroscopic view 
of a 6 mm4 mm disk created by lyophilization of a 
kerateine solution (A). Scanning Electron Microscopy 
(SEM) of lyophilized kerateine disks at (B) 100and (C) 
300. This homogenous porous network was formed by 
spontaneous re-crosslinking of the proteins upon 
exposure to air [10].
 
Fig. 2: SEM image of the keratin/agar scaffold i
that the pores were available in the range of 50
size. The magnification of the SEM was adjusted at 
100×.(A) illustrates the transverse section, while (B) 
demonstrates cross-sectional area of the scaffold [9].
 
The pore size distribution of PLLA and PLLA/NaC1 
composite membranes was determined by a mercury 
intrusion porosimeter (model Poresizer 9220, 
Micromeritics, Norcross, GA) [11].
 
IV. CELL ADHESION AND 
4.1 MTT assay 
International Standard ISO 10993
Evaluation of Medical Devices, Part 5, also describes a 
test by direct contact which allows both qualitative and 
quantitative assessment of cytotoxicity. The sterilised 
scaffold sample is used for MTT 
investigation for adhesion and proliferation of cells is 
made by the observation of the optical density (OD) 
under MTT assay [12].  
Observations are done on the 1st, 3rd, 5th and 7th day of 
cell culture and attached cell percentage is 
using the following equation 
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where 
ODt1= optical density at time t1,  
ODt2=optical density at time t2. 
The OD observed on the 1st day was considered as the 
value of ODt1, while the value of ODt2was opted from 
the OD value taken on the 3rd, 5th and 7th day of culture 
[9]. 
3.2 DAPI assay 
DAPI (4',6-diamidino-2-phenylindole) is a fluorescent 
stain that binds strongly to A-T rich regions in DNA. It is 
used extensively in fluorescence microscopy. As DAPI 
can pass through an intact cell membrane, it can be used 
to stain both live and fixed cells. It passes through the 
membrane less efficiently in live cells and therefore the 
effectiveness of the stain is lower. 
              
Fig.3: Endothelial cells stained with DAPI (blue), 
phalloidin (red) and through immunofluorescence via an 
antibody bound to fluorescein isothiocyanate (FITC) 
(green) image from- https://en.wikipedia.org/wiki/DAPI
 
V. BIODEGRADABILITY
5.1 Weight loss% 
The scaffolds are allowed to swell in physiological 
conditions (37o C in serum-free medium) for 28 days. 
Before test, the initial weight of each vacuum dried films 
(Wo) was recorded. Every four days, three replicate 
specimens were withdrawn from the medium and blotted 
with a filter paper to remove the excess surface water
Then the films were vacuum-dried at room temperature 
for 24 h, weighed again (W dry), and subjected to 
analysis using the equation (4) given below [13].
Weight	Loss	% 
+	,-.
+
x	100                       
 
5.2 Fourier transform infrared spectroscopy
PLLA/keratin scaffolds were immersed in 50 ml 
phosphate buffer saline (PBS, pH 7.4) at 37
periods up to 4 weeks. The degradation medium was 
changed daily for the first week, once at day 10 and day 
14, and then weekly for the rest of the remaining period. 
Scaffolds were taken out at 1, 3, 7, 14, and 28 days. The 
samples were examined by FTIR and XPS (Perkin
PHI 1600ESCA), respectively [14]. 
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Fig.3: FTIR spectra of PLLA/keratin scaffolds as a 
function of degradation periods 
 
VI. CONCLUSION
The suitability of a scaffold for tissue engineering is 
decided by its non-cytotoxic nature, porosity, cell 
proliferation, cell adhesion and biodegradability property. 
These properties are tested using the cytotoxicity test, 
SEM, porosimeter, MTT assays, DAPI assay and FTIR. 
The biomaterial used for the preparation of scaffold for 
the tissue engineering application must fulfil these 
requirements. 
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